141 related articles for article (PubMed ID: 28960449)
1. An integrative review of the psychosocial facilitators and challenges of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
Payk M; Robinson T; Davis D; Atchan M
J Adv Nurs; 2018 Mar; 74(3):528-538. PubMed ID: 28960449
[TBL] [Abstract][Full Text] [Related]
2. Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review.
Alsaleh FM; Smith FJ; Taylor KM
J Clin Pharm Ther; 2012 Apr; 37(2):140-7. PubMed ID: 21729118
[TBL] [Abstract][Full Text] [Related]
3. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
Potti LG; Haines ST
J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
[TBL] [Abstract][Full Text] [Related]
4. Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy.
Indelicato L; Mariano V; Galasso S; Boscari F; Cipponeri E; Negri C; Frigo A; Avogaro A; Bonora E; Trombetta M; Bruttomesso D
Diabet Med; 2017 May; 34(5):691-697. PubMed ID: 28145047
[TBL] [Abstract][Full Text] [Related]
5. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial factors associated with HbA
Schmidt S; Andersen Nexø M; Norgaard O; Willaing I; Pedersen-Bjergaard U; Skinner TC; Nørgaard K
Diabet Med; 2020 Sep; 37(9):1454-1462. PubMed ID: 32579748
[TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous insulin infusion in Type 1 diabetes: patient experiences of 'living with a machine'.
Todres L; Keen S; Kerr D
Diabet Med; 2010 Oct; 27(10):1201-4. PubMed ID: 20873363
[TBL] [Abstract][Full Text] [Related]
8. Barriers and facilitators to accessing insulin pump therapy by adults with type 1 diabetes mellitus: a qualitative study.
Gajewska KA; Biesma R; Bennett K; Sreenan S
Acta Diabetol; 2021 Jan; 58(1):93-105. PubMed ID: 32862261
[TBL] [Abstract][Full Text] [Related]
9. Quality of life activities associated with adherence to insulin infusion pump therapy in the treatment of insulin dependent diabetes mellitus.
Wolf FM; Jacober SJ; Wolf LL; Cornell RG; Floyd JC
J Clin Epidemiol; 1989; 42(12):1129-36. PubMed ID: 2585004
[TBL] [Abstract][Full Text] [Related]
10. Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes.
Barnard KD; Lloyd CE; Skinner TC
Diabet Med; 2007 Jun; 24(6):607-17. PubMed ID: 17367304
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
[TBL] [Abstract][Full Text] [Related]
12. Do perceptions of insulin pump usability impact attitudes toward insulin pump therapy? A pilot study of individuals with type 1 and insulin-treated type 2 diabetes.
Chamberlain JJ; Gilgen E
J Diabetes Sci Technol; 2015 Jan; 9(1):105-10. PubMed ID: 25269659
[TBL] [Abstract][Full Text] [Related]
13. Investigating the Association Between Diabetes Distress and Self-Management Behaviors.
Khan A; Choudhary P
J Diabetes Sci Technol; 2018 Nov; 12(6):1116-1124. PubMed ID: 30101610
[TBL] [Abstract][Full Text] [Related]
14. Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: evaluation after two years of therapy.
Slijper FM; De Beaufort CE; Bruining GJ; De Visser JJ; Aarsen RS; Kicken DA; Van Strik R
Diabete Metab; 1990; 16(4):273-7. PubMed ID: 2265733
[TBL] [Abstract][Full Text] [Related]
15. Insulin pump use in adults with type 1 diabetes--practical issues.
Shetty G; Wolpert H
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S11-6. PubMed ID: 20515299
[TBL] [Abstract][Full Text] [Related]
16. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus--a large-scale multicentre pilot study.
Müller-Godeffroy E; Treichel S; Wagner VM;
Diabet Med; 2009 May; 26(5):493-501. PubMed ID: 19646189
[TBL] [Abstract][Full Text] [Related]
17. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
[TBL] [Abstract][Full Text] [Related]
18. Management of insulin pump therapy in children with type 1 diabetes.
Abdullah N; Pesterfield C; Elleri D; Dunger DB
Arch Dis Child Educ Pract Ed; 2014 Dec; 99(6):214-20. PubMed ID: 25125555
[TBL] [Abstract][Full Text] [Related]
19. Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.
Polsky S; Giordano D; Voelmle MK; Garcetti R; Garg SK
Postgrad Med; 2016 May; 128(4):418-26. PubMed ID: 26924774
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
Peyrot M; Rubin RR
Diabetes Technol Ther; 2009 Jan; 11(1):57-62. PubMed ID: 19132857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
